Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2010
05/12/2010CN1839799B Agglutinin-modified drug delivery system from nose to brain
05/12/2010CN1829523B Viral vectors
05/12/2010CN1798764B Peptide inhibitors of toxins derived from LL-37
05/12/2010CN1740197B Recombination interferon with new space conformation and enhanced effect, its preparing method and application
05/12/2010CN1694960B Use of saccharomyces cerevisiae ERG4 mutants for expressing mammalian glucose transporters
05/12/2010CN1671410B Stabilised solid compositions of factor VII polypeptides
05/12/2010CN1658763B Canola protein isolate compositions
05/12/2010CN1646558B Histone deacetylase inhibitors and process for producing the same
05/12/2010CN1630663B Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
05/12/2010CN1612895B Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/12/2010CN1599750B Cytotoxic protein and utilization thereof
05/12/2010CN1590543B Thermostable Taq polymerase fragment
05/12/2010CN1366991B Application of plant extract for preparing medicine to cure bone absorption increment diseases, and compositon thereof
05/12/2010CN1350578B Recombinant influenza viruses for vaccines and gene therapy
05/12/2010CN101705241A Method for preparing recombined blue algae antiviral protein and application thereof
05/12/2010CN101705231A Apis cerana royal jelly antibacterial peptide AccRoyalisin gene and encoded polypeptide thereof and application thereof
05/12/2010CN101705218A Protease, preparation method of same, as well as application and pharmaceutical formulation thereof
05/12/2010CN101704886A Human alpha-defensin 5 antiviral active mutant polypeptide and preparation method and application
05/12/2010CN101704877A Method for preparing soybean peptide
05/12/2010CN101704876A Novel method for preparing sulfated silk fibroin
05/12/2010CN101703777A Tamper-resistant oral opioid agonist formulations
05/12/2010CN101703767A Preparation method of nibrio parahaemolyticus outer membrane protein VP2850and application of immunity protective function thereof
05/12/2010CN101703765A Preparation method of antiaging buccal tablets
05/12/2010CN101703764A Medicament for treating degenerative osteopathy and preparation method thereof
05/12/2010CN101703763A Production method of human fibrinogen
05/12/2010CN101703762A Use of human interleukin 32 in preparation of medicament for treating or preventing influenza A virus infection
05/12/2010CN101703761A Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/12/2010CN101703760A Methods and compositions for the prevention and treatment of anemia
05/12/2010CN101703759A Lecithin high-calcium capsules and production process thereof
05/12/2010CN101703758A Application of silkworm BmcecD1 gene encoding mature peptide in preparation of drugs against colibacillus or pseudomonas aeruginosa
05/12/2010CN101703480A Gelatin-chitosan/montmorillonite drug carried microspheres and preparation method thereof
05/12/2010CN101703240A Plasmin carrier lipidosome for promoting absorption of intestine and preparation method thereof
05/12/2010CN101481415B Novel PRRS virus receptor and block inhibitor thereof
05/12/2010CN101130090B Application of BRSK2 in producing antidiabetic medicine
05/12/2010CN101108175B Acid-alkaline buffering composition
05/12/2010CN101062948B Monomer quick-effective insulin and preparation method and usage thereof
05/12/2010CN101058604B FK gene, coding protein and application thereof
05/12/2010CN101045744B Anti-titanium oxide from collagen and its use
05/12/2010CN101028522B Function and use of MNSF-beta gene during process of embryo nidation
05/12/2010CN100999752B Antioxydizing peptide mixture from collagen and its preparation process and use
05/11/2010US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein
05/11/2010US7714114 beneficial conjugates of water-soluble polymers and moieties having erythropoietin (EPO) activity; polyethylene glycol (PEG)-EPO conjugates
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010US7714107 Freeze-dried fibrin matrices and methods for preparation thereof
05/11/2010US7714105 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
05/11/2010US7714104 Methods for inhibiting immune complex formation in a subject
05/11/2010US7714103 Peptides, derivatives and analogs thereof, and methods of using same
05/11/2010US7714102 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors; treatment of cancer and bone growth
05/11/2010US7714101 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs
05/11/2010US7714100 Nucleotide sequences coding cardiac marker genes such as, creatine phosphokinase, myoglobin and heart fatty acid binding protein for use in diagnosis/prognosis of heart disease
05/11/2010US7714024 succinyl ester of bimatoprost prodrug is a conjugate comprising a membrane transporter substrate joined to a bioactive agent with a tissue labile linkage, bioconverted back to bimatoprost in body; drug delivery for treating the posterior segment of the eye; tissue-targeted therapy for vision defects
05/11/2010US7714020 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
05/11/2010US7714007 Administering glutaminase inhibitor to a subject suffering from chronic pain at a site of inflammation for therapy of chronic pain
05/11/2010US7713997 Pyridonecarboxylic acid derivatives or salts thereof
05/11/2010US7713947 Cladribine regimen for treating multiple sclerosis
05/11/2010US7713945 Inhibition of dendritic cell function in organ grafts or allogeneic bone marrow transplants by blocking SH2-containing inositol phosphatase (SHIP) expression; preventing immune rejection; reducing antigen presenting cell function; administering interfering RNA specific for SHIP-1 mRNA
05/11/2010US7713944 Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
05/11/2010US7713943 as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target
05/11/2010US7713937 tetrapeptide biodrug for treating or inhibiting a kappa opioid receptor-associated disease pain, pancreatitis, or pruritis, post-surgical pain
05/11/2010US7713936 Abuse-resistant amphetamine prodrugs
05/11/2010US7713935 hormone inhibitor for inhibit thyrotropin-releasing hormone; biodrug peptides treating neuronal cell injury, nervous system disorders, pain, brain disorders, CNS related diseases
05/11/2010US7713934 Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having six or more amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine; wound healing agent, cardiac repair, bone, promote cartilage repair or growth; antirestenosis
05/11/2010US7713933 Pharmaceutical composition containing an activin or inhibin stimulator
05/11/2010US7713932 Calcitonin drug-oligomer conjugates, and uses thereof
05/11/2010US7713931 Cross-linked glycopeptide-cephalosporin antibiotics
05/11/2010US7713930 Acidic insulin preparations having improved stability
05/11/2010US7713929 fusion protein contains a rapid or intermediate acting insulin in combination with a long acting insulin; administered before breakfast, it covers the meal, does not produce hypoglycemia after the meal and provides adequate basal insulin for 24 hours
05/11/2010US7713928 Anticoagulants comprising one or more stabilizers; without pretreatment of drug prior to patient administration; acidity; stable storage at 25 degrees C. for 1 month
05/11/2010US7713927 Antimicrobial peptides
05/11/2010US7713926 Method of producing partial peptide of enolase protein from Plasmodium falciparum
05/11/2010US7713925 Syndecans and angiogenesis
05/11/2010US7713924 Methods for treating conditions associated with the accumulation of excess extracellular matrix
05/11/2010US7713923 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair
05/11/2010US7713915 cloning; ribosome inactivating protein
05/11/2010US7713737 delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker
05/11/2010US7713721 Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
05/11/2010US7713714 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
05/11/2010US7713554 Use of enhanced water to improve blood sugar management
05/11/2010US7713533 treating papilloma by administering biologically a complex of alpha-lactalbumin in the apo folded state and a cis C18 unsaturated fatty acid cofactor which stabilizes the complex in a biologically active form
05/11/2010US7713532 isolated hepatitis B virus (HBV) core-like particle comprising an HBV precore protein, and further not comprising HBV DNA ; vaccines; assay kit comprising an anionic surfactant and an antibody that recognizes amino acids at positions -28 to 150 of the HBV precore protein
05/11/2010US7713523 Solubilized CoQ-10 and carnitine
05/11/2010US7713522 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis
05/11/2010US7713521 MCP1 fusions
05/11/2010US7713303 Collagen-based materials and methods for augmenting intervertebral discs
05/11/2010CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
05/11/2010CA2409674C Glutamic acid decarboxylase (gad) based delivery systems
05/11/2010CA2403871C Inhibition of angiogenesis and tumor growth
05/11/2010CA2395254C Branched polyalkylene glycols
05/11/2010CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines
05/11/2010CA2381205C Method for determining physiological effects of hemoglobin
05/11/2010CA2348739C Methods of conversion of interferon isoforms and products thereof
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/11/2010CA2294709C Compositions and methods for enhancing delivery of therapeutic agents to cells
05/11/2010CA2279517C Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
05/11/2010CA2223261C Improved delivery of diagnostic and therapeutic agents to a target site
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/07/2010CA2684853A1 Dietary supplement for promoting wellness and weight loss and methods of administering the same
05/06/2010WO2010051533A2 Compositions of engineered human arginases and methods for treating cancer
1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 3163